UPDATED Apr 10, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
AIR | €164.22 | -2.3% | 30.1% | €129.3b | €172.40 | PE34.1x | E17.6% | 1.1% | ||
SU | €208.85 | 1.3% | 41.4% | €116.6b | €207.26 | PE29.1x | E10.7% | 1.7% | ||
SAF | €205.40 | -0.4% | 49.4% | €84.9b | €202.47 | PE24.7x | E5.7% | 1.1% | ||
DG | €112.90 | -4.5% | 4.1% | €64.4b | €133.50 | PE13.7x | E5.2% | 4.0% | ||
SGO | €72.72 | -0.5% | 43.7% | €36.5b | €79.47 | PE13.7x | E8.0% | 2.9% | ||
HO | €154.95 | -2.9% | 10.0% | €32.0b | €161.50 | PE33.7x | E15.1% | 2.2% | ||
LR | €95.30 | -1.0% | 17.1% | €25.0b | €94.53 | PE21.7x | E4.1% | 2.2% | ||
AM | €202.20 | -1.7% | 9.2% | €16.0b | €212.93 | PE23x | E17.1% | 1.7% | ||
EN | €36.08 | -4.8% | 13.6% | €13.5b | €38.82 | PE13x | E8.2% | 5.3% | ||
FGR | €99.18 | -4.1% | -3.0% | €9.3b | €122.79 | PE9.2x | E5.2% | 4.1% | ||
RXL | €25.14 | 2.1% | 25.1% | €7.5b | €26.38 | PE9.7x | E4.7% | 4.8% | ||
RE | €175.00 | 0% | 53.5% | €5.7b | n/a | PE19.3x | n/a | 4.2% | ||
ALO | €14.90 | 4.9% | -37.6% | €5.7b | €18.98 | PB0.6x | E111.8% | 1.7% | ||
NEX | €97.00 | 0.6% | 18.5% | €4.2b | €102.78 | PE19.2x | E12.5% | 2.4% | ||
MLHK | €117.00 | 5.4% | 5.4% | €4.2b | n/a | PE129.2x | n/a | n/a | ||
FII | €24.80 | 3.3% | 0.4% | €1.1b | €25.82 | PE30x | E30.5% | 1.3% | ||
MTU | €25.55 | 1.4% | 16.7% | €977.6m | €30.00 | PE6.8x | E-6.3% | 2.5% | ||
MRN | €36.25 | -0.3% | -7.5% | €876.9m | €50.03 | PE10.7x | E12.4% | 3.4% | ||
THEP | €88.20 | -1.5% | -2.2% | €811.5m | €88.67 | PE13.9x | E2.7% | 2.4% | ||
MLPLC | €496.00 | 0% | n/a | €647.6m | n/a | n/a | n/a | 1.0% | ||
TKTT | €9.22 | 1.8% | -25.0% | €603.4m | €10.00 | PE29.6x | n/a | 0% | ||
JCQ | €18.30 | -1.2% | 4.0% | €410.9m | €21.00 | PE8.1x | E-1.4% | 5.5% | ||
EXA | €23.20 | -4.7% | 30.8% | €394.5m | €26.00 | PS1.1x | E87.9% | n/a | ||
EXE | €56.80 | 0.7% | 17.8% | €385.2m | €69.08 | PE9.1x | E7.2% | 2.8% |